{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T22:06:23Z","timestamp":1769810783677,"version":"3.49.0"},"reference-count":47,"publisher":"Pan African Medical Journal","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PAMJ"],"abstract":"<jats:p>Introduction: medication non-adherence in patients with type 2 diabetes substantially contributes to poor glycemic control and increases the risk of complications. This study aimed to assess the prevalence of medication non-adherence and to identify its associated factors among Moroccan patients with type 2 diabetes.\n\n \n\nMethods: a cross-sectional study was conducted in the Endocrinology Department of Ibn Rochd University Hospital in Casablanca, Morocco. A total of 329 adult patients with type 2 diabetes were included. Medication adherence was evaluated using the 8-item Morisky Medication Adherence Scale (MMAS-8). Bivariate logistic regression was performed to examine associations between non-adherence and socio-demographic, clinical, treatment, and behavioral-related factors.\n\n \n\nResults: among the participants, 52.6% exhibited low adherence, followed by 20.4% with moderate adherence and 27.1% with high adherence to antidiabetic medications. Socio-demographic characteristics, including age, gender, marital status, and education, showed no significant association with non-adherence. Several clinical and behavioral factors, however, were significantly related to adherence patterns. Higher odds of non-adherence were observed among patients who did not benefit from therapeutic education (p=0.009), individuals not performing self-monitoring of blood glucose (p&lt;0.001), and those using phytotherapy (p=0.03). Additional determinants of poor adherence included higher out-of-pocket medication costs (p=0.043), drug shortages in health facilities (p=0.013), forgetfulness (p&lt;0.001), absence of diabetic symptoms (p&lt;0.001), and psychological barriers such as mistrust in physicians (p&lt;0.001). Conversely, better adherence was associated with the combined use of oral antidiabetic drugs and insulin, follow-up with a general physician (p=0.036), dietary compliance (p&lt;0.001), and regular physical activity (p=0.021).\n\n \n\nConclusion: medication non-adherence remains highly prevalent among patients with type 2 diabetes. Our findings highlight the importance of strengthening therapeutic education, improving access to medications, and promoting healthy lifestyle behaviors to enhance adherence. Targeted interventions addressing both behavioral and healthcare system-related barriers are essential to improve long-term diabetes outcomes in the Moroccan context.<\/jats:p>","DOI":"10.11604\/pamj.2025.52.187.48329","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:50:01Z","timestamp":1769773801000},"source":"Crossref","is-referenced-by-count":0,"title":["Medication non-adherence in patients with type 2 diabetes: a cross-sectional study in Morocco"],"prefix":"10.11604","author":[{"given":"Haidar","family":"Ibtisam","sequence":"first","affiliation":[{"name":"Laboratory of Biology and Health, Faculty of Sciences Ben M'Sik, Hassan II University, Casablanca, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chadli","family":"Asma","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition, Ibn Rochd University Hospital, Casablanca, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6798-0301","authenticated-orcid":false,"given":"Nassim Essabah","family":"Haraj","sequence":"additional","affiliation":[{"name":"Laboratory of Neurosciences and Mental Health, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6804-8279","authenticated-orcid":false,"given":"Siham","family":"El Azizi","sequence":"additional","affiliation":[{"name":"Laboratory of Neurosciences and Mental Health, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iggar","family":"Malak","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition, Ibn Rochd University Hospital, Casablanca, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bounjerte","family":"Imane","sequence":"additional","affiliation":[{"name":"Laboratory of Biology and Health, Faculty of Sciences Ben M'Sik, Hassan II University, Casablanca, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kettani","family":"Anass","sequence":"additional","affiliation":[{"name":"Laboratory of Biology and Health, Faculty of Sciences Ben M'Sik, Hassan II University, Casablanca, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7411-0523","authenticated-orcid":false,"given":"Rachid","family":"Saile","sequence":"additional","affiliation":[{"name":"Laboratory of Biology and Health, Faculty of Sciences Ben M'Sik, Hassan II University, Casablanca, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bennani","family":"Houda","sequence":"additional","affiliation":[{"name":"Laboratory of Biology and Health, Faculty of Sciences Ben M'Sik, Hassan II University, Casablanca, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4870","published-online":{"date-parts":[[2025,12,28]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"El-Kebbi IM, Bidikian NH, Hneiny L, Nasrallah MP. Epidemiology of type 2 diabetes in the Middle East and North Africa: Challenges and call for action. World J Diabetes. 2021 Sep 15;12(9):1401-1425. PubMed | Google Scholar","DOI":"10.4239\/wjd.v12.i9.1401"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014 Feb;103(2):137-49. PubMed | Google Scholar","DOI":"10.1016\/j.diabres.2013.11.002"},{"key":"ref2","unstructured":"Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023 Jul 15;402(10397):203-234. PubMed | Google Scholar"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Moradi-Lakeh M, Forouzanfar MH, El Bcheraoui C, Daoud F, Afshin A, Hanson SW. High Fasting Plasma Glucose, Diabetes, and Its Risk Factors in the Eastern Mediterranean Region, 1990-2013: Findings From the Global Burden of Disease Study 2013. Diabetes Care. 2017 Jan;40(1):22-29. PubMed | Google Scholar","DOI":"10.2337\/dc16-1075"},{"key":"ref4","unstructured":"International Diabetes Federation. IDF Middle-East and North Africa. Accessed 17th November, 2025."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Tazi MA, Abir-Khalil S, Chaouki N, Cherqaoui S, Lahmouz F, Sra\u00efri JE et al. Prevalence of the main cardiovascular risk factors in Morocco: results of a National Survey, 2000. J Hypertens. 2003 May;21(5):897-903. PubMed | Google Scholar","DOI":"10.1097\/00004872-200305000-00013"},{"key":"ref6","unstructured":"World Health Organization. Global report on diabetes. 2016."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Huang J, Ding S, Xiong S, Liu Z. Medication Adherence and Associated Factors in Patients With Type 2 Diabetes: A Structural Equation Model. Front Public Health. 2021;9:730845. PubMed | Google Scholar","DOI":"10.3389\/fpubh.2021.730845"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28(2):103-117. PubMed | Google Scholar","DOI":"10.1016\/0168-8227(95)01064-K"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"AlQarni K, AlQarni EA, Naqvi AA, AlShayban DM, Ghori SA, Haseeb A et al. Assessment of Medication Adherence in Saudi Patients With Type II Diabetes Mellitus in Khobar City, Saudi Arabia. Front Pharmacol. 2019;10:1306. PubMed | Google Scholar","DOI":"10.3389\/fphar.2019.01306"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Alqarni AM, Alrahbeni T, Qarni AA, Qarni HMA. Adherence to diabetes medication among diabetic patients in the Bisha governorate of Saudi Arabia - a cross-sectional survey. Patient Prefer Adherence. 2018 Dec 24:13:63-71. PubMed | Google Scholar","DOI":"10.2147\/PPA.S176355"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Murwanashyaka J de D, Ndagijimana A, Biracyaza E, Sunday FX, Umugwaneza M. Non-adherence to medication and associated factors among type 2 diabetes patients at Clinique Medicale Fraternite, Rwanda: a cross-sectional study. BMC Endocr Disord. 2022;22(1):219. PubMed | Google Scholar","DOI":"10.1186\/s12902-022-01133-0"},{"key":"ref12","unstructured":"Achouri MY, Tounsi F, Messaoud M, Senoussaoui A, Ben Abdelaziz A. Prevalence of poor medication adherence in type 2 diabetics in North Africa. Systematic review and meta-analysis. Tunis Med. 2021 Octobre;99(10):932-945. PubMed | Google Scholar"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Houguig K, Rkha S, Rayadi M, Ouzennou N. Factors Influencing Therapeutic Observance in Diabetic Subjects in the Province of Essaouira (Morocco): A Cross-Sectional Study. Ethiop J Health Sci. 2022;32(4):747-754. PubMed | Google Scholar","DOI":"10.4314\/ejhs.v32i4.11"},{"key":"ref14","unstructured":"Syst\u00e8me de sant\u00e9 et offre de soins. 2015."},{"key":"ref15","unstructured":"Centre Hospitalo-Universitaire Ibn Rochd. Service d\u2019endocrinologie diabetologie maladies metabolique et nutrition. Accessed 10th November, 2025."},{"key":"ref16","unstructured":"Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench. 2013 Winter;6(1):14-7. PubMed | Google Scholar"},{"key":"ref17","unstructured":"World Health Organization. Obesity and overweight. 2025. Accessed 10th November, 2025."},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Ashur ST, Shamsuddin K, Shah SA, Bosseri S, Morisky DE. Reliability and known-group validity of the Arabic version of the 8-item Morisky Medication Adherence Scale among type 2 diabetes mellitus patients. East Mediterr Health J. 2015 Dec 13;21(10):722-8 PubMed | Google Scholar","DOI":"10.26719\/2015.21.10.722"},{"key":"ref19","unstructured":"Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009 Jan;15(1):59-66. PubMed"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Ali RA, Hamed EN, Al-Torky MA, Atia FM. Medication Adherence and Predictors of Non-Adherence among Patients with Type 2 Diabetes Mellitus in Sohag, Egypt. The Egyptian Journal of Community Medicine. 2021;39(4):51-56. Google Scholar","DOI":"10.21608\/ejcm.2021.202264"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Murwanashyaka J de D, Ndagijimana A, Biracyaza E, Sunday FX, Umugwaneza M. Non-adherence to medication and associated factors among type 2 diabetes patients at Clinique Medicale Fraternite, Rwanda: a cross-sectional study. BMC Endocr Disord. 2022;22(1):219. PubMed | Google Scholar","DOI":"10.1186\/s12902-022-01133-0"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Almetrek M, Alqahtani M, Al Mudawi A, Assiri A, Alfayi A, Alotaibi N et al. Adherence of Type 2 Diabetic Patients to Antidiabetic Medications and its Associated Factors in Najran Armed Forces Hospital, Saudi Arabia. MEWFM. 2023. Google Scholar","DOI":"10.5742\/MEWFM.2023.95256237"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Waari G, Mutai J, Gikunju J. Medication adherence and factors associated with poor adherence among type 2 diabetes mellitus patients on follow-up at Kenyatta National Hospital, Kenya. The Pan African Medical Journal. 2018;29:82. PubMed | Google Scholar","DOI":"10.11604\/pamj.2018.29.82.12639"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Abate TW. Medication non-adherence and associated factors among diabetes patients in Felege Hiwot Referral Hospital, Bahir Dar city administration, Northwest Ethiopia. BMC Res Notes. 2019;12(1):175. PubMed | Google Scholar","DOI":"10.1186\/s13104-019-4205-4"},{"key":"ref25","unstructured":"World Health Organization. WHO. Adherence to Long-Term Therapies: Evidence for Action, 2003. 2003. Accessed 5th November, 2025."},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Mirghani HO. An evaluation of adherence to anti-diabetic medications among type 2 diabetic patients in a Sudanese outpatient clinic. The Pan African Medical Journal. 2019;34:34. PubMed | Google Scholar","DOI":"10.11604\/pamj.2019.34.34.15161"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Ahmad NS, Ramli A, Islahudin F, Paraidathathu T. Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Prefer Adherence. 2013 Jun 17:7:525-30. PubMed | Google Scholar","DOI":"10.2147\/PPA.S44698"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Nashat Hegazy N. Quality of Care and Medication Adherence among Patients with Type (2) Diabetes Mellitus. The Egyptian Family Medicine Journal. 2017;1(2):1-13. Google Scholar","DOI":"10.21608\/efmj.2019.67587"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Khan AR, Al-Abdul Lateef ZN, Al Aithan MA, Bu-Khamseen MA, Ibrahim IA, Khan SA. Factors contributing to non-compliance among diabetics attending primary health centers in the Al Hasa district of Saudi Arabia. J Family Community Med. 2012;19(1):26-32. PubMed | Google Scholar","DOI":"10.4103\/2230-8229.94008"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Aker O, Hamooz S, Sweileh W. Rate of compliance among patients with diabetes mellitus and hypertension.. An-Najah University Journal for Research - A (Natural Sciences). 2004;19(1):1-11. Google Scholar","DOI":"10.35552\/anujr.a.19.1.612"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Park KA, Kim JG, Kim BW, Kam S, Kim KY, Ha SW et al. Factors that Affect Medication Adherence in Elderly Patients with Diabetes Mellitus. Korean Diabetes J. 2010;34(1):55-65. PubMed | Google Scholar","DOI":"10.4093\/kdj.2010.34.1.55"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Wong MC, Kong AP, So WY, Jiang JY, Chan JC, Griffiths SM. Adherence to oral hypoglycemic agents in 26,782 Chinese patients: a cohort study. J Clin Pharmacol. 2011 Oct;51(10):1474-82. PubMed | Google Scholar","DOI":"10.1177\/0091270010382911"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Lunghi C, Zongo A, Moisan J, Gr\u00e9goire J-P, Gu\u00e9nette L. The impact of incident depression on medication adherence in patients with type 2 diabetes. Diabetes Metab. 2017 Dec;43(6):521-528. PubMed | Google Scholar","DOI":"10.1016\/j.diabet.2017.07.003"},{"key":"ref34","unstructured":"Mwangasha FM, Nyamu DG, Tirop LJ. Factors impacting on diabetes knowledge, medication adherence and glycemic control among adult diabetics visiting a county teaching and referral hospital in Kenya: a cross-sectional study. The Pan African Medical Journal. 2021;40:5. PubMed | Google Scholar"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Aminde LN, Tindong M, Ngwasiri CA, Aminde JA, Njim T, Fondong AA et al. Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. BMC Endocr Disord. 2019;19(1):35. PubMed | Google Scholar","DOI":"10.1186\/s12902-019-0360-9"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Gill G. Diabetes in Africa - Puzzles and challenges. Indian J Endocrinol Metab. 2014;18(3):249-251. PubMed | Google Scholar","DOI":"10.4103\/2230-8210.131111"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Amara A, Ghammam R, Zammit N, Ben Fredj S, Maatoug J, Ghanam H. Adherence to medication among Tunisian adults with type 2 diabetes. European Journal of Public Health. 2020;30. Google Scholar","DOI":"10.1093\/eurpub\/ckaa166.1151"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Jannoo Z, Mamode Khan N. Medication Adherence and Diabetes Self-Care Activities Among Patients With Type 2 Diabetes Mellitus. Value Health Reg Issues. 2019 May;18:30-35. PubMed | Google Scholar","DOI":"10.1016\/j.vhri.2018.06.003"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Hamdi MS, Elhaj WB, Boukhris I, Nacef IB, Kechaou I, Azzabi S et al. Observance m\u00e9dicamenteuse chez le diab\u00e9tique: facteurs d\u00e9terminants et int\u00e9r\u00eat de l\u00b4\u00e9ducation th\u00e9rapeutique du patient. EM-Consulte. 2021;82(5):352. Google Scholar","DOI":"10.1016\/j.ando.2021.08.272"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Yusuff KB, Obe O, Joseph BY. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria. Pharm World Sci. 2008;30(6):876-883. PubMed | Google Scholar","DOI":"10.1007\/s11096-008-9243-2"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Badi S, Abdalla A, Altayeb L, Noma M, Ahmed MH. Adherence to Antidiabetic Medications Among Sudanese Individuals With Type 2 Diabetes Mellitus: A Cross-Sectional Survey. J Patient Exp. 2020 Apr;7(2):163-168. PubMed | Google Scholar","DOI":"10.1177\/2374373519831073"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Benrazavy L, Khalooei A. Medication Adherence and its Predictors in Type 2 Diabetic Patients Referring to Urban Primary Health Care Centers in Kerman City, Southeastern Iran. Shiraz E-Medical Journal. 2019. Google Scholar","DOI":"10.5812\/semj.84746"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Polonsky WH. Poor medication adherence in diabetes: What\u00b4s the problem? J Diabetes. 2015;7(6):777-778. PubMed | Google Scholar","DOI":"10.1111\/1753-0407.12306"},{"key":"ref44","unstructured":"Beverly EA, Worley M, Prokopakis K, Ivanov N. Patient-physician communication and diabetes self-care. J Clin Outcomes Manag. 2016 Nov;23(11):509-18. Google Scholar"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Ali MD, Ahmad A, Banu N, Patel M, Ghosn SA, Eltrafi Z. Evaluation of drug utilisation pattern and cost associated with diabetes mellitusType 2 management in Saudi Arabia. Braz J Pharm Sci. 2023;58:e20681. Google Scholar","DOI":"10.1590\/s2175-97902022e20681"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Rwegerera GM. Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study. The Pan African Medical Journal. 2014;17:252. PubMed | Google Scholar","DOI":"10.11604\/pamj.2014.17.252.2972"}],"container-title":["Pan African Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:50:09Z","timestamp":1769773809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.panafrican-med-journal.com\/content\/article\/52\/187\/full\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,28]]},"references-count":47,"URL":"https:\/\/doi.org\/10.11604\/pamj.2025.52.187.48329","relation":{},"ISSN":["1937-8688"],"issn-type":[{"value":"1937-8688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,28]]},"article-number":"48329"}}